Novel pyridine derivatives as potent and selective CB2 cannabinoid receptor agonists

被引:14
|
作者
Chu, Guo-Hua [1 ]
Saeui, Christopher T. [1 ]
Worm, Karin [1 ]
Weaver, Damian G. [1 ]
Goodman, Allan J. [1 ]
Broadrup, Robert L. [1 ]
Cassel, Joel A. [2 ]
DeHaven, Robert N. [2 ]
LaBuda, Christopher J. [2 ]
Koblish, Michael [2 ]
Brogdon, Bernice [3 ]
Smith, Steve [3 ]
Le Bourdonnec, Bertrand [1 ]
Dolle, Roland E. [1 ]
机构
[1] Adolor Corp, Dept Chem, Exton, PA 19341 USA
[2] Adolor Corp, Dept Pharmacol, Exton, PA 19341 USA
[3] Adolor Corp, Dept DMPK, Exton, PA 19341 USA
关键词
Cannabinoid receptors; Selective CB2 agonists; Pain; Pyridine derivatives; PAIN; BINDING; ACTIVATION; DISCOVERY; RAT;
D O I
10.1016/j.bmcl.2009.08.063
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Replacement of the phenyl ring in our previous ( morpholinomethyl) aniline carboxamide cannabinoid receptor ligands with a pyridine ring led to the discovery of a novel chemical series of CB2 ligands. Compound 3, that is, 2,2-dimethyl-N-(5-methyl-4-(morpholinomethyl)pyridin-2-yl)butanamide was identified as a potent and selective CB2 agonist exhibiting in vivo efficacy after oral administration in a rat model of neuropathic pain. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5931 / 5935
页数:5
相关论文
共 50 条
  • [1] Novel azoles as potent and selective cannabinoid CB2 receptor agonists
    Harnett, Jeremiah J.
    Dolo, Christine
    Viossat, Isabelle
    Auger, Florence
    Ferrandis, Eric
    Bigg, Dennis
    Auguet, Michel
    Auvin, Serge
    Chabrier, Pierre-E.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2015, 25 (01) : 88 - 91
  • [2] Sulfonamide derivatives as new potent and selective CB2 cannabinoid receptor agonists
    Ohta, Hiroshi
    Ishizaka, Tomoko
    Yoshinaga, Mitsukane
    Morita, Aki
    Tomishima, Yasumitsu
    Toda, Yoshihisa
    Saitoa, Shuj
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (18) : 5133 - 5135
  • [3] Imine derivatives as new potent and selective CB2 cannabinoid receptor agonists with an analgesic action
    Ohta, Hiroshi
    Ishizaka, Tomoko
    Tatsuzuki, Makoto
    Yoshinaga, Mitsukane
    Iida, Izumi
    Yamaguchi, Tomomi
    Tomishima, Yasumitsu
    Futaki, Nobuko
    Todac, Yoshihisa
    Saito, Shuji
    BIOORGANIC & MEDICINAL CHEMISTRY, 2008, 16 (03) : 1111 - 1124
  • [4] Novel pyrazolylidene derivatives as selective CB2 agonists
    Liu, Bo
    Wang, Xueqing
    Dart, Michael
    Meyer, Michael
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2011, 241
  • [5] Novel benzimidazole derivatives as selective CB2 agonists
    Page, Daniel
    Balaux, Elise
    Boisvert, Luc
    Liu, Ziping
    Milburn, Claire
    Tremblay, Maxime
    Wei, Zhongyong
    Woo, Simon
    Luo, Xuehong
    Cheng, Yun-Xing
    Yang, Hua
    Srivastava, Sanjay
    Zhou, Fei
    Brown, William
    Tomaszewski, Miroslaw
    Walpole, Christopher
    Hodzic, Leila
    St-Onge, Stephane
    Godbout, Claude
    Salois, Dominic
    Payza, Keymal
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (13) : 3695 - 3700
  • [6] Resorcinol derivatives:: A novel template for the development of cannabinoid CB1/CB2 and CB2-selective agonists
    Wiley, JL
    Beletskaya, ID
    Ng, EW
    Dai, ZM
    Crocker, PJ
    Mahadevan, A
    Razdan, RK
    Martin, BR
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (02): : 679 - 689
  • [7] Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists
    Han, Sangdon
    Thatte, Jayant
    Buzard, Daniel J.
    Jones, Robert M.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (21) : 8224 - 8256
  • [8] Novel benzimidazole derivatives as selective CB2 inverse agonists
    Pagé, D
    Brochu, MC
    Yang, H
    Brown, W
    St-Onge, S
    Martin, E
    Salois, D
    LETTERS IN DRUG DESIGN & DISCOVERY, 2006, 3 (05) : 298 - 303
  • [9] N-Alkylidenearylcarboxamides as new potent and selective CB2 cannabinoid receptor agonists with good oral bioavailability
    Ohta, Hiroshi
    Ishizaka, Tomoko
    Tatsuzuki, Makoto
    Yoshinaga, Mitsukane
    Iida, Izumi
    Tomishima, Yasumitsu
    Toda, Yoshihisa
    Saito, Shuji
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2007, 17 (22) : 6299 - 6304
  • [10] Discovery and optimization of novel purines as potent and selective CB2 agonists
    Hollinshead, Sean P.
    Astles, Peter C.
    Chambers, Mark G.
    Johnson, Michael P.
    Palmer, John
    Tidwell, Michael W.
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2012, 22 (15) : 4962 - 4966